Botulinum toxin A injections improve apraxia of eyelid opening without overt blepharospasm associated with neurodegenerative diseases

Comment

Eva Lopez Valdes et al. Mov Disord. 2008.

. 2008 Apr 15;23(5):773; author reply 773.

doi: 10.1002/mds.21816.

No abstract available

Comment on

Botulinum toxin A injections improve apraxia of eyelid opening without overt blepharospasm associated with neurodegenerative diseases.
Kanazawa M, Shimohata T, Sato M, Onodera O, Tanaka K, Nishizawa M. Kanazawa M, et al. Mov Disord. 2007 Mar 15;22(4):597-8. doi: 10.1002/mds.21367. Mov Disord. 2007. PMID: 17266083 No abstract available.

Botulinum toxin A injections improve apraxia of eyelid opening without overt blepharospasm associated with neurodegenerative diseases.
Kanazawa M, Shimohata T, Sato M, Onodera O, Tanaka K, Nishizawa M. Kanazawa M, et al. Mov Disord. 2007 Mar 15;22(4):597-8. doi: 10.1002/mds.21367. Mov Disord. 2007. PMID: 17266083 No abstract available.
Combination of blepharospasm and apraxia of eyelid opening: a condition resistant to treatment.
Rana AQ, Shah R. Rana AQ, et al. Acta Neurol Belg. 2012 Mar;112(1):95-6. doi: 10.1007/s13760-012-0019-z. Epub 2012 Jan 24. Acta Neurol Belg. 2012. PMID: 22427299
What is new in the era of focal dystonia treatment? Botulinum injections and more.
Cetinkaya A, Brannan PA. Cetinkaya A, et al. Curr Opin Ophthalmol. 2007 Sep;18(5):424-9. doi: 10.1097/ICU.0b013e3282be9032. Curr Opin Ophthalmol. 2007. PMID: 17700237 Review.
Levator aponeurosis dehiscence in a patient treated with botulinum toxin for blepharospasms and eyelid apraxia.
Verhulst S, Smet H, De Wilde F, Tassignon MJ. Verhulst S, et al. Bull Soc Belge Ophtalmol. 1994;252:51-3. Bull Soc Belge Ophtalmol. 1994. PMID: 7894756
Disease-oriented approach to botulinum toxin use.
Jankovic J. Jankovic J. Toxicon. 2009 Oct;54(5):614-23. doi: 10.1016/j.toxicon.2008.11.013. Epub 2008 Dec 6. Toxicon. 2009. PMID: 19073203 Review.